Mingyan Zhou
No. 368 Yehai Road
Haikou, 570311, China
Haikou, 570311, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Kaempferide in Alpinia officinarum Hance Exerts Anti-Hepatocellular Carcinoma Activity by Inhibiting Mitophagy Through Downregulation of BNIP3L.
Journal: Journal of cellular and molecular medicine
Published: March 09, 2026
Globulol from Alpinia oxyphylla Miq. Enhances the pharmacological effects of anti-PD-1 drugs in combination by reducing PD-L1 expression in hepatocellular carcinoma.
Journal: Frontiers in pharmacology
Published: October 20, 2025
DPHC from Alpinia officinarum Hance specifically modulates the function of CENPU in the cell cycle and apoptosis to ameliorate hepatocellular carcinoma.
Journal: Journal of ethnopharmacology
Published: January 20, 2025
Study on the Mechanism of Alpinia officinarum Hance in the Improvement of Insulin Resistance through Network Pharmacology, Molecular Docking and in vitro Experimental Verification.
Journal: Current computer-aided drug design
Published: May 24, 2024
Kaempferol from Alpinia officinarum hance induces G2/M cell cycle arrest in hepatocellular carcinoma cells by regulating the ATM/CHEK2/KNL1 pathway.
Journal: Journal of ethnopharmacology
Published: April 22, 2024
Physicochemical Characterization, Antioxidant and Anticancer Activity Evaluation of an Acidic Polysaccharide from Alpinia officinarum Hance.
Journal: Molecules (Basel, Switzerland)
Published: February 17, 2024
Integrating network pharmacology, bioinformatics, and experimental validation to unveil the molecular targets and mechanisms of galangin for treating hepatocellular carcinoma.
Journal: BMC complementary medicine and therapies
Published: December 18, 2023
Investigation of the Potential Mechanism of Alpinia officinarum Hance in Improving Type 2 Diabetes Mellitus Based on Network Pharmacology and Molecular Docking.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: July 29, 2022
A diarylheptanoid compound from Alpinia officinarum Hance ameliorates high glucose-induced insulin resistance by regulating PI3K/AKT-Nrf2-GSK3β signaling pathways in HepG2 cells.
Journal: Journal of ethnopharmacology
Published: March 06, 2022
DPHC From Alpinia officinarum Ameliorates Oxidative Stress and Insulin Resistance via Activation of Nrf2/ARE Pathway in db/db Mice and High Glucose-Treated HepG2 Cells.
Journal: Frontiers in pharmacology
Published: October 11, 2021
Comparative analysis of bioactive constituents and pharmacological activities from different parts of Nauclea officinalis.
Journal: Biomedical chromatography : BMC
Published: March 19, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026